---
abstract: The IGF receptor type 1 IGF-1R pathway is frequently deregulated in human
  tumors and has become a target of interest for anti-cancer therapy.
authors: Gong Y, Yao E, Shen R, Goel A, Arcila M, Teruya-Feldstein J, Zakowski MF,
  Frankel S, Peifer M, Thomas RK, Ladanyi M and Pao W.
cancertypes: []
contact:
  email: william.pao@vanderbilt.edu
  name: William Pao
counts:
  biosamples: 84
  samples_acgh: 84
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:19806209
- geo:GSE17247
geo_data:
  geo_json:
    coordinates:
    - -74.01
    - 40.71
    type: Point
  info:
    city: New York City
    continent: North America
    country: United States
    label: New York City, United States, North America
    precision: city
journal: 'PLoS One 4, 10 (2009): e7273.'
label: 'Gong et al. (2009): High Expression Levels of Total Igf-1r and Sensitivity
  of Nsclc Cells in Vitro to an Anti-Igf-1r ...'
notes: ~
pmid: 19806209
title: High Expression Levels of Total Igf-1r and Sensitivity of Nsclc Cells in Vitro
  to an Anti-Igf-1r Antibody (R1507).
year: 2009
